These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34314327)

  • 1. Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Dreyer SD; Torres J; Stoddard M; Leavitt E; Sutton A; Aleshin M; Crew A; Worswick S
    Cutis; 2021 Jun; 107(6):E22-E28. PubMed ID: 34314327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid remission of Stevens-Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature.
    Wang R; Zhong S; Tu P; Li R; Wang M
    Dermatol Ther; 2019 Jul; 32(4):e12832. PubMed ID: 30659711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
    Schneider JA; Cohen PR
    Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Pham CH; Gillenwater TJ; Nagengast E; McCullough MC; Peng DH; Garner WL
    Burns; 2019 Nov; 45(7):1634-1638. PubMed ID: 31466921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tian CC; Ai XC; Ma JC; Hu FQ; Liu XT; Luo YJ; Tan GZ; Zhang JM; Li XQ; Guo Q; Zeng FQ; Shi ZR; Wang L
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):360-365.e1. PubMed ID: 35598882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Mittmann N; Chan B; Knowles S; Cosentino L; Shear N
    Am J Clin Dermatol; 2006; 7(6):359-68. PubMed ID: 17173470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
    J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
    Ozerturk S; Derici Yildirim D; Arikoglu T; Kuyucu S; Kont Ozhan A
    Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):22-32. PubMed ID: 38484271
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM; Kanigsberg ND; Ramien ML
    J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
    Houschyar KS; Tapking C; Borrelli MR; Puladi B; Ooms M; Wallner C; Duscher D; Pförringer D; Rein S; Reumuth G; Schulz T; Nietzschmann I; Maan ZN; Grieb G; Philipp-Dormston WG; Branski LK; Siemers F; Lehnhardt M; Schmitt L; Yazdi AS
    J Wound Care; 2021 Dec; 30(12):1012-1019. PubMed ID: 34881995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of mortality risk and immunosuppressive therapy for Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome using the TriNetX research network.
    Ozhathil DK; Powell CM; Corley CV; Golovko G; Song J; El Ayadi A; Wolf SE; Kahn SA
    Burns; 2024 Feb; 50(1):75-86. PubMed ID: 37734977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children.
    Koh MJ; Tay YK
    J Am Acad Dermatol; 2010 Jan; 62(1):54-60. PubMed ID: 19811851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.